Global Stem Cell Therapy Market – Analysis and Forecast, 2019-2029

Focus on Treatment Type, Cell Source, Indication,11 Countries’ Data, and Competitive Landscape

Published Year: 2019
SKU: BHP0740SA

5000

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

2 Scope of the Work

         2.1    Overview: Report Scope
         2.2    Segmentation of the Global Stem Cell Therapy Market
         2.3    Assumptions and Limitations
         2.4    Key Questions Answered in the Report
         2.5    Base Year and Forecast Period

3 Research Methodology

    3.1    Overview: Report Methodology

4 Global Stem Cell Therapy Market

         4.1    Market Overview
         4.2    Introduction of Stem Cell Therapy
         4.3    Application of Stem Cells in Different Therapeutic Areas
         4.4    Market Dynamics
         4.5    Global Market Scenario
         4.6    Assumptions and Limitations

5 Competitive Landscape

         5.1    Overview
         5.2    Key Developments and Strategies
                  5.2.1    Collaborations, and Partnerships
                  5.2.2    Approvals and Clinical Studies
                  5.2.3    Funding
                  5.2.4    Business Expansions
                  5.2.5    Product Launches and Developments
                  5.2.6    Mergers and Acquisitions
                  5.2.7    Others
         5.3    Market Share Analysis

6 Industry Insights

        6.1    Regulatory Scenario
         6.2    Regulatory Designations
         6.3    Expedited Designation Vs. Traditional Approval Timelines:
         6.4    Regulatory Challenges:

7 Global Stem Cell Therapy Market (by Treatment Type)

         7.1    Overview
         7.2    Key Trends of the Global Stem Cell Therapy Market (by Treatment Type)
         7.3    Autologous Treatment
         7.4    Allogenic Treatment

8 Global Stem Cell Therapy Market (by Cell Source)

         8.1    Overview
         8.2    Key Trends of the Global Stem Cell Therapy Market (by Cell Source)
         8.3    Bone Marrow and Peripheral Blood
         8.4    Adipose Tissue
         8.5    Placenta and Umbilical Cord
         8.6    Embryo
         8.7    Others

9 Global Stem Cell Therapy Market (by Indication)

         9.1    Overview
         9.2    Key Trends of the Global Stem Cell Therapy Market (by Indication)
         9.3    Orthopaedic and Dental
         9.4    Wounds and Injuries
         9.5    Cardiology and Neurology
         9.6    Immunology and Inflammatory
         9.7    Oncology and Metabolism
         9.8    Others

10 Global Stem Cell Therapy Market (by Region)

           10.1    Overview
           10.2    North America
                      10.2.1    Overview
                      10.2.2    U.S.
                      10.2.3    Canada
           10.3    Europe
                      10.3.1    Overview
                      10.3.2    Germany
                      10.3.3    U.K.
                      10.3.4    France
                      10.3.5    Italy
                      10.3.6    Rest-of-Europe
            10.4    Asia-Pacific
                       10.4.1    Overview
                       10.4.2    Japan
                       10.4.3    Australia
                       10.4.4    China
                       10.4.5    South Korea
                       10.4.6    India
                       10.4.7    Rest-of-Asia-Pacific
            10.5    Rest-of-the-World
                       10.5.1    Overview
                       10.5.2    Middle East and Africa
                       10.5.3    Latin America

11 Company Profiles

           11.1    Overview
           11.2    AlloSource
                      11.2.1    Company Overview
                      11.2.2    Role of AlloSource in the Global Stem Cell Therapy Market
                      11.2.3    SWOT Analysis
           11.3    ANTEROGEN.CO., LTD.
                      11.3.1    Company Overview
                      11.3.2    Role of ANTEROGEN.CO., LTD. in the Global Stem Cell Therapy Market
                      11.3.3    SWOT Analysis
           11.4    Athersys Inc.
                      11.4.1    Company Overview
                      11.4.2    Role of Athersys Inc. in the Global Stem Cell Therapy Market
                      11.4.3    SWOT Analysis
           11.5    CORESTEM, Inc
                      11.5.1    Company Overview
                      11.5.2    Role of CORESTEM, Inc in the Global Stem Cell Therapy Market
                      11.5.3    Financials
                      11.5.4    SWOT Analysis
            11.6    FUJIFILM Cellular Dynamics, Inc.
                      11.6.1    Company Overview
                      11.6.2    Role of FUJIFILM Cellular Dynamics, Inc. in the Global Stem Cell Therapy Market
                      11.6.3    Financials
                      11.6.4    SWOT Analysis
           11.7    JCR Pharmaceuticals Co., Ltd.
                      11.7.1    Company Overview
                      11.7.2    Role of JCR Pharmaceuticals Co., Ltd. in the Global Stem Cell Therapy Market
                      11.7.3    Financials
                      11.7.4    SWOT Analysis
            11.8    Mesoblast Ltd
                      11.8.1    Company Overview
                      11.8.2    Role of Mesoblast Ltd in the Global Stem Cell Therapy Market
                      11.8.3    Financials
                      11.8.4    SWOT Analysis
            11.9    NuVasive, Inc.
                      11.9.1    Company Overview
                      11.9.2    Role of NuVasive, Inc. in the Global Stem Cell Therapy Market
                      11.9.3    Financials
                      11.9.4    SWOT Analysis
           11.10   Orthofix Holdings, Inc.
                      11.10.1    Company Overview
                      11.10.2    Role of Orthofix Holdings, Inc. in the Global Stem Cell Therapy Market
                      11.10.3    Financials
                      11.10.4    SWOT Analysis
           11.11   Osiris Therapeutics, Inc.
                      11.11.1    Company Overview
                      11.11.2    Role of Osiris Therapeutics, Inc. in the Global Stem Cell Therapy Market
                      11.11.3    Financials
                      11.11.4    SWOT Analysis
           11.12   Regenexx
                      11.12.1    Company Overview
                      11.12.2    Role of Regenexx in the Global Stem Cell Therapy Market
                      11.12.3    SWOT Analysis
           11.13   Reliance Life Sciences Private Limited
                      11.13.1    Company Overview
                      11.13.2    Role of Reliance Life Sciences Private Limited in the Global Stem Cell Therapy Market
                      11.13.3    SWOT Analysis
           11.14   Takeda Pharmaceutical Company Limited
                      11.14.1    Company Overview
                      11.14.2    Role of Takeda Pharmaceutical Company Limited in the Global Stem Cell Therapy Market
                      11.14.3    Financials
                      11.14.4    SWOT Analysis
           11.15   U.S. Stem Cell, Inc.
                      11.15.1    Company Overview
                      11.15.2    Role of U.S. Stem Cell, Inc. in the Global Stem Cell Therapy Market
                      11.15.3    SWOT Analysis
           11.16   Vericel Corporation
                      11.16.1    Company Overview
                      11.16.2    Role of Vericel Corporation in the Global Stem Cell Therapy Market
                      11.16.3    Financials
                      11.16.4    SWOT Analysis

List of Tables

Table 1:    Global Stem Cell Therapy Market, 2018 and 2029
Table 6.1:    Regulatory Authorities/Associations/Consortiums of the Global Stem Cell Therapy Market
Table 7.1:    Examples of Companies Offering Autologous Stem Cell Therapy Products
Table 7.2:    Examples of Companies Offering Allogenic Stem Cell Therapy Products
Table 8.1:    Examples of Companies Offering Stem Cell Therapy Products Derived from Bone Marrow and Peripheral Blood
Table 8.2:    Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Adipose Tissue
Table 8.3:    Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Either Placenta or Umbilical Cord
Table 8.4:    Examples of Companies Developing Stem Cell Therapy Products Derived from Embryonic Stem Cells
Table 8.5:    Examples of Companies Developing Stem Cell Therapy Products from Different Cell Sources
Table 9.1:    Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Orthopaedic and Dental
Table 9.2:    Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Wounds and Injuries
Table 9.3:    Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Cardiology and Neurology
Table 9.4:    Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Immunology and Inflammatory
Table 9.5:    Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Oncology and Metabolism
Table 9.6:    Application of Stem Cells in Disease Therapeutics

List of Figures

Figure 1:    Global Stem Cell Therapy Market Segmentation, 2018 and 2029
Figure 2:    Share of Key Developments and Strategies, January 2016-July 2019
Figure 3:    Global Stem Cell Therapy Market Share (by Company), 2018
Figure 4:    Global Stem Cell Therapy Market Share (by Treatment Type), 2018 and 2029
Figure 5:    Global Stem Cell Therapy Market Share (by Cell Source), 2018 and 2029
Figure 6:    Global Stem Cell Therapy Market Share (by Indication), 2018 and 2029
Figure 7:    Global Stem Cell Therapy Market Share (by Region), 2017 and 2023
Figure 2.1:    Global Stem Cell Therapy Market Segmentation
Figure 3.1:    Global Stem Cell Therapy Market Research Methodology
Figure 3.2:    Primary Research
Figure 3.3:    Secondary Research
Figure 3.4:    Data Triangulation
Figure 3.5:    Bottom-up Approach (Segment-wise Analysis)
Figure 3.6:    Top-Down Approach (Segment-wise Analysis)
Figure 3.7:    Assumptions and Limitations
Figure 4.1:    Drivers and Challenges of the Global Stem Cell Therapy Market
Figure 4.2:    Global Stem Cell Therapy Market, 2018-2029
Figure 5.1:    Competitive Landscape (January 2016-June 2019)
Figure 5.2:    Share of Key Developments and Strategies, January 2016-July 2019
Figure 5.3:    Collaborations, and Partnerships (by Company), January 2016 and June 2019
Figure 5.4:    Approvals and Clinical Studies (by Company), January 2016 and June 2019
Figure 5.5:    Fundings (by Company), January 2016 and June 2019
Figure 5.6:    Business Expansions (by Company), January 2016 and June 2019
Figure 5.7:    Product Launches and Developments (by Company), January 2016 and June 2019
Figure 5.8:    Mergers and Acquisitions (by Company), January 2016 and June 2019
Figure 5.9:    Market Share Analysis of Global Stem Cell Therapy Market, 2018
Figure 7.1:    Stem Cells Therapy Market Segmentation (by Treatment Type)
Figure 7.2:    Global Stem Cell Therapy Market (by Treatment Type), 2018-2029
Figure 7.3:    Global Autologous Stem Cell Therapy Market, 2018-2029
Figure 7.4:    Global Stem Cell Therapy Market, by Allogenic Treatment, 2018-2029
Figure 8.1:    Stem Cells Therapy Market Segmentation (by Cell Source)
Figure 8.2:    Global Stem Cell Therapy Market (by Cell Source), 2018-2029
Figure 8.3:    Global Stem Cell Therapy Market (Bone Marrow and Peripheral Blood),  2018-2029
Figure 8.4:    Global Stem Cell Therapy Market (Adipose Tissue), 2018-2029
Figure 8.5:    Global Stem Cell Therapy Market (Umbilical Cord and Placenta), 2018-2029
Figure 8.6:    Global Stem Cell Therapy Market (Embryo), 2018-2029
Figure 8.7:    Global Stem Cell Therapy Market (Others), 2018-2029
Figure 9.1:    Stem Cells Therapy Market Segmentation (by Indication)
Figure 9.2:    Global Stem Cell Therapy Market (by Indication), 2018-2029
Figure 9.3:    Global Stem Cell Therapy Market (Orthopaedic and Dental), 2018-2029
Figure 9.4:    Global Stem Cell Therapy Market (Wounds and Injuries), 2018-2029
Figure 9.5:    Global Stem Cell Therapy Market (Cardiology and Neurology), 2018-2029
Figure 9.6:    Global Stem Cell Therapy Market (Immunology and Inflammatory), 2018-2029
Figure 9.7:    Global Stem Cell Therapy Market (Oncology and Metabolism), 2018-2029
Figure 9.8:    Global Stem Cell Therapy Market (Others), 2018-2029
Figure 10.1:    Global Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.2:    North America: Stem Cell Therapy Market, 2018-2029
Figure 10.3:    North America: Market Dynamics
Figure 10.4:    North America: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.5:    U.S.: Stem Cell Therapy Market, 2018-2029
Figure 10.6:    Canada: Stem Cell Therapy Market, 2018-2029
Figure 10.7:    Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.8:    Europe: Market Dynamics
Figure 10.9:    Europe: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.10:    Germany: Stem Cell Therapy Market, 2018-2029
Figure 10.11:    U.K.: Stem Cell Therapy Market, 2018-2029
Figure 10.12:    France: Stem Cell Therapy Market, 2018-2029
Figure 10.13:    Italy: Stem Cell Therapy Market, 2018-2029
Figure 10.14:    Rest-of-Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.15:    Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.16:    Asia-Pacific: Market Dynamics
Figure 10.17:    Asia-Pacific: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.18:    Japan: Stem Cell Therapy Market, 2018-2029
Figure 10.19:    Australia: Stem Cell Therapy Market, 2018-2029
Figure 10.20:    China: Stem Cell Therapy Market, 2018-2029
Figure 10.21:    South Korea: Stem Cell Therapy Market, 2018-2029
Figure 10.22:    India: Stem Cell Therapy Market, 2018-2029
Figure 10.23:    Rest-of-Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.24:    Rest-of-the-World: Stem Cell Therapy Market, 2018-2029
Figure 10.25:    Rest-of-the-World: Market Dynamics
Figure 10.26:    Rest-of-the-World: Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.27:    Middle East and Africa: Stem Cell Therapy Market, 2018-2029
Figure 10.28:    Latin America: Stem Cell Therapy Market, 2018-2029
Figure 11.1:    Shares of Key Company Profiles
Figure 11.2:    AlloSource: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.3:    AlloSource: SWOT Analysis
Figure 11.4:    ANTEROGEN.CO., LTD.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.5:    ANTEROGEN.CO., LTD.: SWOT Analysis
Figure 11.6:    Athersys Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.7:    Athersys Inc.: SWOT Analysis
Figure 11.8:    CORESTEM, Inc: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.9:    CORESTEM, Inc: Overall Financials, 2016-2018
Figure 11.10:    CORESTEM, Inc: R&D Expenditure (2016-2018)
Figure 11.11:    CORESTEM, Inc: SWOT Analysis
Figure 11.12:    FUJIFILM Cellular Dynamics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.13:    FUJIFILM Cellular Dynamics, Inc.: Overall Financials, 2016-2018
Figure 11.14:    FUJIFILM Cellular Dynamics, Inc.: Revenue (by Business Segment),  2016-2018
Figure 11.15:    FUJIFILM Cellular Dynamics, Inc.: Revenue (by Region), 2016-2018
Figure 11.16:    FUJIFILM Cellular Dynamics, Inc.: R&D Expenditure (2016-2018)
Figure 11.17:    FUJIFILM Cellular Dynamics, Inc.: SWOT Analysis
Figure 11.18:    JCR Pharmaceuticals Co., Ltd.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.19:    JCR Pharmaceuticals Co., Ltd.: Overall Financials, 2016-2018
Figure 11.20:    JCR Pharmaceuticals Co., Ltd.: Revenue (by Segment), 2016-2018
Figure 11.21:    JCR Pharmaceuticals Co., Ltd.: SWOT Analysis
Figure 11.22:    Mesoblast Ltd: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.23:    Mesoblast Ltd: Overall Financials, 2016-2018
Figure 11.24:    Mesoblast Ltd: R&D Expenditure (2016-2018)
Figure 11.25:    Mesoblast Ltd: SWOT Analysis
Figure 11.26:    NuVasive, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.27:    NuVasive, Inc.: Overall Financials, 2016-2018
Figure 11.28:    NuVasive, Inc.: Revenue (by Segment), 2016-2018
Figure 11.29:    NuVasive, Inc.: Revenue (by Region), 2016-2018
Figure 11.30:    NuVasive, Inc.: R&D Expenditure (2016-2018)
Figure 11.31:    NuVasive, Inc.: SWOT Analysis
Figure 11.32:    Orthofix Holdings, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.33:    Orthofix Holdings, Inc.: Overall Financials, 2016-2018
Figure 11.34:    Orthofix Holdings, Inc.: Revenue (by Segment), 2016-2018
Figure 11.35:    Orthofix Holdings, Inc.: Revenue (by Country), 2016-2018
Figure 11.36:    Orthofix Holdings, Inc.: R&D Expenditure (2016-2018)
Figure 11.37:    Orthofix Holdings, Inc.: SWOT Analysis
Figure 11.38:    Osiris Therapeutics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.39:    Osiris Therapeutics, Inc.: Overall Financials, 2016-2018
Figure 11.40:    Osiris Therapeutics, Inc.: Revenue (by Product), 2016-2018
Figure 11.41:    Osiris Therapeutics, Inc.: R&D Expenditure (2016-2018)
Figure 11.42:    Osiris Therapeutics, Inc.: SWOT Analysis
Figure 11.43:    Regenexx: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.44:    Regenexx: SWOT Analysis
Figure 11.45:    Reliance Life Sciences Private Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.46:    Reliance Life Sciences Private Limited: SWOT Analysis
Figure 11.47:    Takeda Pharmaceutical Company Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.48:    Takeda Pharmaceutical Company Limited: Overall Financials, 2016-2018
Figure 11.49:    Takeda Pharmaceutical Company Limited: Revenue (by Region), 2016-2018
Figure 11.50:    Takeda Pharmaceutical Company Limited: R&D Expenditure (2016-2018)
Figure 11.51:    Takeda Pharmaceutical Company Limited: SWOT Analysis
Figure 11.52:    U.S. Stem Cell, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.53:    U.S. Stem Cell, Inc.: SWOT Analysis
Figure 11.54:    Vericel Corporation: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.55:    Vericel Corporation: Overall Financials, 2016-2018
Figure 11.56:    Vericel Corporation: Revenue (by Product), 2016-2018
Figure 11.57:    Vericel Corporation: R&D Expenditure (2016-2018)
Figure 11.58:    Vericel Corporation: SWOT Analysis

You may also like

Published Year: 2019

Global Cell and Gene Therapy Market: Focus on Products, Applications, Regions and Competitive Landsc

The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a...

 
Published Year: 2018

Global Recombinant Cell Culture Supplements Market – Analysis and Forecast, 2018 to 2028: Focus on

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and...

 
Published Year: 2018

Global Regenerative Medicines Market - Analysis and Forecast (2017-2025): (Focus on Therapy, Applica

The global regenerative medicines market is expected to reach $50.55 billion by...

 

Global Stem Cell Therapy Market – Analysis and Forecast, 2019-2029

Focus on Treatment Type, Cell Source, Indication,11 Countries’ Data, and Competitive Landscape